ESR1 and breast cancer: Our findings suggest that OC use and first-degree family history of breast cancer may be associated with ESR1 A908G mutation-positive breast cancer, whereas reproductive factors associated with longer exposure to endogenous hormones may be related to mutation-negative breast cancer.